Valneva SE (VALN)
NASDAQ·Healthcare·Biotechnology
$5.49
+0.00%
Mkt Cap $903.47M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 16, 2026 | $52.46M | $55.48M | +5.76% | -$0.17 | -$0.68 | -293.06% | — | — |
| Q4 2025 Nov 20, 2025 | $48.85M | $34.45M | -29.49% | -$0.30 | -$0.61 | -103.33% | — | — |
| Q3 2025 Aug 12, 2025 | $39.10M | $56.91M | +45.54% | -$0.27 | -$0.16 | +40.74% | — | — |
| Q2 2025 May 7, 2025 | $44.49M | $53.97M | +21.32% | -$0.31 | -$0.13 | +58.06% | — | — |
| Q1 2025 Mar 20, 2025 | $36.70M | $54.82M | +49.38% | -$0.22 | -$0.54 | -145.45% | — | — |
| Q4 2024 Nov 7, 2024 | $55.89M | $50.26M | -10.08% | -$0.30 | -$0.15 | +50.00% | — | — |
| Q3 2024 Aug 13, 2024 | $45.10M | $40.92M | -9.26% | -$0.39 | -$0.37 | +5.13% | — | — |
| Q2 2024 May 7, 2024 | $36.00M | $35.19M | -2.25% | $0.77 | $0.89 | +15.58% | — | — |
| Q1 2024 Mar 20, 2024 | $76.82M | $46.08M | -40.01% | $0.20 | -$0.50 | -350.00% | — | — |
| Q4 2023 Nov 9, 2023 | $45.07M | $40.16M | -10.90% | -$0.51 | -$0.54 | -5.88% | — | — |
| Q3 2023 Sep 21, 2023 | $34.46M | $43.89M | +27.37% | -$0.36 | -$0.26 | +27.78% | — | — |
| Q2 2023 May 4, 2023 | $33.11M | $36.43M | +10.04% | -$0.35 | -$0.28 | +20.00% | — | — |
| Q1 2023 Mar 23, 2023 | $158.27M | $120.00M | -24.18% | $0.29 | -$0.65 | -324.14% | — | — |
| Q4 2022 Nov 10, 2022 | $115.89M | $153.01M | +32.02% | -$0.14 | $1.33 | +1050.00% | — | — |
| Q3 2022 Aug 11, 2022 | $81.95M | $74.66M | -8.89% | -$1.32 | -$2.86 | -116.67% | — | — |
| Q2 2022 May 5, 2022 | $22.92M | $24.17M | +5.44% | -$0.92 | -$0.54 | +41.30% | — | — |
| Q1 2022 Mar 24, 2022 | $174.40M | $157.72M | -9.56% | $0.33 | $2.03 | +515.15% | — | — |
| Q4 2021 Nov 18, 2021 | $25.29M | $25.94M | +2.56% | $1.68 | -$1.85 | -210.34% | — | — |
| Q3 2021 Aug 10, 2021 | $24.29M | $28.81M | +18.64% | -$0.58 | -$1.22 | -110.34% | — | — |
| Q2 2021 May 20, 2021 | — | $27.31M | — | — | -$0.35 | — | — | — |